Literature DB >> 2289992

The emergence of antibiotic resistance: myths and facts in clinical practice.

J M Hamilton-Miller1.   

Abstract

Selection pressure, caused by the use of antibiotics--especially in hospitals--is the main factor responsible for the emergence of antibiotic-resistant bacteria. Resistance can arise endogenously by mutation (one-step, as found for Mycobacterium tuberculosis to rifampicin, or multi-step, as in gonococci to benzylpenicillin), or exogenously by transfer of R-factors. Mechanisms of resistance may involve a decrease in permeability, chemical modification of the antibiotic, or a change in the affinity of the target site. There are many misconceptions concerning the incidence, nature and spread of antibiotic resistance, and some of the most important of these are discussed. The emergence and spread of resistance can be controlled by adhering to antibiotic policies and by preventing or controlling outbreaks of infection. The importance of resistant organisms can be diminished by the development of new antibiotic agents, preferably containing new chemical entities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2289992     DOI: 10.1007/bf01709702

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  38 in total

1.  Staphylococcal infection resistant to chloramphenicol, erythromycin, and novobiocin; effect of antibiotic combinations on the emergence of resistant strains.

Authors:  M BARBER; A CSILLAG; A J MEDWAY
Journal:  Br Med J       Date:  1958-12-06

Review 2.  Development of new beta-lactam antibiotics derived from natural and synthetic sources.

Authors:  R Kirrstetter; W Dürckheimer
Journal:  Pharmazie       Date:  1989-03       Impact factor: 1.267

3.  Resistance to nalidixic acid. A misconception due to underdosage.

Authors:  T A Stamey; J Bragonje
Journal:  JAMA       Date:  1976-10-18       Impact factor: 56.272

Review 4.  Estimating worldwide current antibiotic usage: report of Task Force 1.

Authors:  N F Col; R W O'Connor
Journal:  Rev Infect Dis       Date:  1987 May-Jun

Review 5.  Use and abuse of antibiotics.

Authors:  J M Hamilton-Miller
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

Review 6.  The new quinolones: back to the future.

Authors:  J Davies
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

7.  Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

Authors:  C C Sanders; W E Sanders; R V Goering; V Werner
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

8.  Trimethoprim resistance and trimethoprim usage in and around The Royal Free Hospital in 1985.

Authors:  J M Hamilton-Miller; D Purves
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

9.  Resistance to antibiotics at medical centres in different parts of the world.

Authors:  T F O'Brien
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

10.  Influence of aminoglycoside usage on susceptibilities.

Authors:  D J Flournoy
Journal:  Chemotherapy       Date:  1985       Impact factor: 2.544

View more
  4 in total

Review 1.  Challenges of antibacterial discovery.

Authors:  Lynn L Silver
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 2.  Discovery and development of new antibiotics: the problem of antibiotic resistance.

Authors:  L L Silver; K A Bostian
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

3.  Assessing antibacterial pharmacoeconomics in the intensive care unit.

Authors:  M C Birmingham; J M Hassett; J J Schentag; J A Paladino
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

4.  Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens.

Authors:  Berthony Deslouches; Jonathan D Steckbeck; Jodi K Craigo; Yohei Doi; Timothy A Mietzner; Ronald C Montelaro
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.